Clinical Laserthermia Systems AB (OSTO:CLS B) Construction In Progress: kr14.97 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLS B Clinical Laserthermia Systems AB OSTO:CLS B
54 GF Score
Price kr1.93
GF Value kr2.67
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB Construction In Progress?

Clinical Laserthermia Systems AB OSTO:CLS B -2.53% 54 Construction In Progress is kr14.97 Mil as of Jun. 2026. GuruFocus rates OSTO:CLS B with a GF Score™ of 54/100 and a GF Value™ of kr2.67 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Clinical Laserthermia Systems AB's quarterly construction in progress increased from Dec. 2025 (kr0.00 Mil) to Mar. 2026 (kr10.83 Mil) and increased from Mar. 2026 (kr10.83 Mil) to Jun. 2026 (kr14.97 Mil).

Clinical Laserthermia Systems AB Construction In Progress Historical Data

* Premium members only.

The historical data trend for Clinical Laserthermia Systems AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinical Laserthermia Systems AB Construction In Progress Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Clinical Laserthermia Systems AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.21 9.82 0.00 10.83 14.97
OSTO:CLS B
54GF Score
Clinical Laserthermia Systems AB OSTO:CLS B
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinical Laserthermia Systems AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of kr14.97 Mil mean?
Clinical Laserthermia Systems AB (OSTO:CLS B) has a Construction In Progress of kr14.97 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Clinical Laserthermia Systems AB and its competitors.
Is Clinical Laserthermia Systems AB's Construction In Progress too high?
Clinical Laserthermia Systems AB's current Construction In Progress is kr14.97 Mil. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's Construction In Progress compare to ABT and SYK?
Clinical Laserthermia Systems AB's Construction In Progress of kr14.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Clinical Laserthermia Systems AB and its competitors. Clinical Laserthermia Systems AB's current Construction In Progress is kr14.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (OSTO:CLS B) is currently considered Modestly Undervalued. The stock's GF Value™ is kr2.67, compared to a current price of kr1.93 — trading 27.7% below its estimated fair value. The current Construction In Progress is kr14.97 Mil. Clinical Laserthermia Systems AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (OSTO:CLS B), the current Construction In Progress is kr14.97 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinical Laserthermia Systems AB (OSTO:CLS B) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of kr1.93 is trading 27.7% below its estimated GF Value™ of kr2.67. GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.

Key valuation signals for OSTO:CLS B:

  • Construction In Progress: kr14.97 Mil
  • GF Value™: kr2.67 vs. price of kr1.93 (27.7% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the OSTO:CLS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinical Laserthermia Systems AB Business Description

Other Exchanges LS60:Germany
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
54GF Score

Get the complete analysis for OSTO:CLS B

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.93
Price
kr2.67
GF Value